Filing Details
- Accession Number:
- 0001493152-18-008549
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-12 18:30:31
- Reporting Period:
- 2018-06-08
- Accepted Time:
- 2018-06-12 18:30:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1133416 | Galectin Therapeutics Inc | GALT | Pharmaceutical Preparations (2834) | 043562325 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1260641 | C James Czirr | C/O Galectin Therapeutics, Inc. Peachtree Ind. Blvd. Suite 240 Norcross, GA 30071 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-06-08 | 50,000 | $5.64 | 3,069,786 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2018-06-08 | 60,000 | $6.08 | 3,009,786 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- Common shares should pursuant to a trading plan pursuant to Rule 10b5-1. Price represents the gross sales price less commissions and brokerage fees.
- 10X Fund, L.P. has direct beneficial ownership of all the securities owned by 10X Fund, L.P. 10X Capital Management, LLC, a Florida limited liability company, is the general partner of 10X Fund, L.P., a Delaware limited partnership, and may be deemed to have indirect beneficial ownership of all or a portion of the securities owned directly by 10X Fund, L.P. 10X Capital Management, LLC disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
Billionaire Hedge Funds
